α-甲基酪氨酸减轻创伤性脑损伤小鼠模型急性心血管和行为后遗症
该研究将小鼠随机分为α-甲基酪氨酸(αMT,50 mg·kg⁻¹·d⁻¹)组或溶剂对照组,在控制性皮质撞击致TBI后给药1周。αMT阻断了TBI诱导的血压和心脏反应性升高,减少血脑屏障渗漏并改善行为结局。TBI降低Adra2c转录、增强Nkcc1表达并降低Kcc2转录;αMT阻止TBI诱导的Nkcc1上调,但不逆转TBI对Kcc2表达的影响,同时降低Ae3转录。作者认为αMT可能通过减弱Nkcc1表达、减少血脑屏障渗漏及降低中枢儿茶酚胺和交感输出而对TBI治疗有益,并发现Kcc2与氯/碳酸氢盐交换体之间此前未报告的关系,设计调控急性脑损伤后中枢神经元内氯浓度的试验时应考虑。
要点
- 小鼠控制性皮质撞击TBI后,αMT(50 mg·kg⁻¹·d⁻¹)给药1周阻断了TBI诱导的血压升高和心脏反应性增强。
- αMT减少TBI后血脑屏障渗漏并改善行为结局。
- TBI增强Nkcc1表达、降低Kcc2转录;αMT阻止TBI诱导的Nkcc1上调,但不逆转TBI对Kcc2表达的影响。
- αMT降低Ae3转录;作者报告了Kcc2与氯/碳酸氢盐交换体之间此前未报告的关系。
- 作者认为αMT可能通过减弱Nkcc1表达、减少血脑屏障渗漏和降低中枢儿茶酚胺及交感输出而对TBI治疗有益。
适用人群与场景
- 控制性皮质撞击致创伤性脑损伤的小鼠模型,TBI后给药1周。
处置流程与药物剂量
- αMT 50 mg·kg⁻¹·d⁻¹,TBI后给药1周;原文未写明给药途径和频次。
研究设计与关键结果
- 小鼠随机接受αMT(50 mg·kg⁻¹·d⁻¹)或溶剂对照1周;αMT阻断TBI诱导的血压升高和心脏反应性增强。
- αMT减少血脑屏障渗漏并改善行为结局。
- TBI降低Adra2c转录、增强Nkcc1表达并降低Kcc2转录;αMT阻止TBI诱导的Nkcc1上调,但不逆转TBI对Kcc2表达的影响;αMT降低Ae3转录。
- 作者报告了Kcc2与氯/碳酸氢盐交换体之间此前未报告的关系。
证据类型、等级与局限
- 证据类型:小鼠随机对照原始研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为αMT可能通过减弱Nkcc1表达、减少血脑屏障渗漏及降低中枢儿茶酚胺和交感输出而对TBI治疗有益。
- 作者认为设计调控急性脑损伤后中枢神经元内氯浓度的试验时,应考虑Kcc2与氯/碳酸氢盐交换体之间的关系。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Increased catecholamines contribute to heightened cardiovascular reactivity and behavioral deficits after traumatic brain injury (TBI); adrenergic receptor blockade has limited success in reducing adverse sequelae of TBI. Injury-induced increases in the synthesis of catecholamines could contribute to adverse outcomes in TBI. Inhibition of catecholamine synthesis with alpha-methyltyrosine (αMT) could offer a benefit after TBI.
METHODS: Original research trial in mice randomized to αMT (50 mg·kg -1 ·d -1 ) or vehicle for 1 week after TBI induced by controlled cortical impact. Primary outcomes of cardiovascular reactivity and behavioral deficits were assessed after 1 week. Secondary outcomes included blood brain barrier permeability and quantification of gene transcription whose products determine intraneuronal chloride concentrations, the release of catecholamines, and activation of the sympathetic nervous system. These genes were the alpha-2 adrenergic receptor ("Adra2c"), the sodium-potassium-chloride cotransporter ("Nkcc1"), and the potassium chloride cotransporter ("Kcc2"). We also assessed the effect of TBI and αMT on the neuronal chloride/bicarbonate exchanger ("Ae3").
RESULTS: Traumatic brain injury-induced increases in blood pressure and cardiac reactivity were blocked by αMT. Inhibition of catecholamine synthesis decreased blood brain barrier leakage and improved behavioral outcomes after TBI. Traumatic brain injury diminished the transcription of Adra2c and enhanced expression of Nkcc1 while reducing Kcc2 transcription; αMT prevented the induction of the Nkcc1 by TBI without reversing the effects of TBI on Kcc2 expression; αMT also diminished Ae3 transcription.
CONCLUSION: Traumatic brain injury acutely increases cardiovascular reactivity and induces behavioral deficits in an αMT-sensitive manner, most likely by inducing Nkcc1 gene transcription. Alpha-methyltyrosine may prove salutary in the treatment of TBI by attenuating the enhanced expression of Nkcc1, minimizing blood brain barrier leakage, and diminishing central catecholamine and sympathetic output. We also found an unreported relationship between Kcc2 and the chloride/bicarbonate exchanger, which should be considered in the design of trials planned to manipulate central intraneuronal chloride concentrations following acute brain injury.
参考来源
- Woodman R, Miller C, Student J, et al. Alpha-methyltyrosine reduces the acute cardiovascular and behavioral sequelae in a murine model of traumatic brain injury. J Trauma Acute Care Surg. 2023. PMID: 37165479. doi:10.1097/TA.0000000000004023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。